BBWI Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 3.25%, SMA50 11.28%, SMA200 -12.29%). The stock’s 14-day RSI is 58.92 (neutral), while the ATR of 0.98 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -44.95% below its high and over 61.47% above its low. Average 10-day trading volume of 4.41 million shares is below the 3-month average of 7.27 million, indicating normal recent market interest.

Bath & Body Works, Inc. has 206.19 million shares outstanding. The public float is 205.20 million shares, elevated short interest at 11.87% of float. This equals 21.09 million shares. The short ratio is 2.81 days. Institutional investors hold 102.37% of the float. Insiders own 0.37%. TURNEY SHAREN J holds 446.70 thousand shares, Nash Sarah E has 285.52 thousand shares and Boswell Gina has 242.99 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Bath & Body Works, Inc. last paid a dividend of 0.8 per share, this equals a trailing yield of roughly 2.36%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $59.17. This means the shares are trading below this model’s fair value.

Bath & Body Works, Inc. (NYSE:BBWI) closed at $23.05 USD, gaining $0.81 (3.64%) from the previous close of $22.24. The stock is currently mid-range between its 52-week high and low $14.28 and $41.87. With a market capitalization of about $4.75 billion, Bath & Body Works, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~1.46). Key stats such as the average daily volume over the past year has been around 7.47 million shares, volume is running light vs its 52-week average. Headquartered in Columbus, OH, Bath & Body Works, Inc. operates in the Consumer Cyclical sector and the Specialty Retail industry. Led by CEO Daniel Heaf, the company employs approximately 8,975 people and listed since April 01, 1982. Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products.

Bath & Body Works, Inc. trades at a P/E ratio of 7.01, slightly below the S&P 500 average, with a price-to-sales ratio of 0.65 and a price-to-book ratio of -3.08 indicating negative book value, which may reflect financial stress. The P/FCF stands at 5.04, also below market averages.

Bath & Body Works, Inc. generated EPS of $3.25 over the past year. Five-year average earnings growth is 3.75%. Wall Street analysts project EPS growth of -6.01% annually over the next five years. The latest quarter delivered EPS of $0.35. The next quarter is forecast at $1.75. Next year's EPS is expected at $7.15. Analyst sentiment is neutral. Analyst rating data shows there are 16 Strong Buy ratings, 6 Buy ratings, 16 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $48.00 to $17.00. The high target offers 108.24% upside. The low target suggests -26.25% downside. The mean target is $33.20. This offers 44.03% upside. Bath & Body Works, Inc. earnings surprise history is a mixed track record. The quarter that ended November 20, 2025, missed forecasts by -12.5%.

Bath & Body Works, Inc. (NYSE:BBWI) shares are flat 7.82% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Bath & Body Works, Inc. trading at a premium to the broader market with a P/E of 7.01. Analyst sentiment is mixed, with the majority of ratings in Hold territory and a mean price target of $43.08, suggesting 86.9% upside. Our AI forecast model points to short-term weakness (-3.3% over two weeks), a medium-term fall (-4.3% over three months), and a longer-term loss (-27.33% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Bath & Body Works, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -3.3%, with price expected at $22.29 by February 20, 2026, within a range of $21.54 to $23.09 3-Month Outlook: Projected fall of -4.3%, reaching $22.06 by May 06, 2026, with a range of $19.74 to $23.77. 1-Year Outlook: Projected loss of -27.33%, with price at $16.75 by February 05, 2027, within a range of $14.61 to $19.18.